These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort. Bérard A, Zhao JP, Sheehy O. BMJ Open; 2017 Jan 12; 7(1):e013372. PubMed ID: 28082367 [Abstract] [Full Text] [Related]
4. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design. Furu K, Kieler H, Haglund B, Engeland A, Selmer R, Stephansson O, Valdimarsdottir UA, Zoega H, Artama M, Gissler M, Malm H, Nørgaard M. BMJ; 2015 Apr 17; 350():h1798. PubMed ID: 25888213 [Abstract] [Full Text] [Related]
13. Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD. Margulis AV, Abou-Ali A, Strazzeri MM, Ding Y, Kuyateh F, Frimpong EY, Levenson MS, Hammad TA. Pharmacoepidemiol Drug Saf; 2013 Sep 17; 22(9):942-51. PubMed ID: 23733623 [Abstract] [Full Text] [Related]
18. Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring. Huybrechts KF, Hernández-Díaz S, Straub L, Gray KJ, Zhu Y, Patorno E, Desai RJ, Mogun H, Bateman BT. JAMA; 2018 Dec 18; 320(23):2429-2437. PubMed ID: 30561479 [Abstract] [Full Text] [Related]
20. Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects. Anderson KN, Lind JN, Simeone RM, Bobo WV, Mitchell AA, Riehle-Colarusso T, Polen KN, Reefhuis J. JAMA Psychiatry; 2020 Dec 01; 77(12):1246-1255. PubMed ID: 32777011 [Abstract] [Full Text] [Related] Page: [Next] [New Search]